In agreement, NLRP3 activation in OSA patients has been shown to induce the release of the coagulation initiator tissue factor (TF), that promotes systemic coagulation, thrombosis, and atherosclerosis progression [13,14]. This evidence concerns the gene NLRP3 and atherosclerosis.